TR199501631A2 - Piperazin türevleri,bu bilesimleri iceren ilaclar,bunlarin kullanimi ve imal edilmesi usulü. - Google Patents
Piperazin türevleri,bu bilesimleri iceren ilaclar,bunlarin kullanimi ve imal edilmesi usulü.Info
- Publication number
- TR199501631A2 TR199501631A2 TR95/01631A TR9501631A TR199501631A2 TR 199501631 A2 TR199501631 A2 TR 199501631A2 TR 95/01631 A TR95/01631 A TR 95/01631A TR 9501631 A TR9501631 A TR 9501631A TR 199501631 A2 TR199501631 A2 TR 199501631A2
- Authority
- TR
- Turkey
- Prior art keywords
- compounds
- manufacturing
- piperazine derivatives
- drugs containing
- drugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4446300A DE4446300A1 (de) | 1994-12-23 | 1994-12-23 | Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE19533224A DE19533224A1 (de) | 1994-12-23 | 1995-09-08 | Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199501631A2 true TR199501631A2 (tr) | 1996-07-21 |
Family
ID=25943252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR95/01631A TR199501631A2 (tr) | 1994-12-23 | 1995-12-21 | Piperazin türevleri,bu bilesimleri iceren ilaclar,bunlarin kullanimi ve imal edilmesi usulü. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5700801A (tr) |
| EP (1) | EP0718287A3 (tr) |
| JP (1) | JPH08231509A (tr) |
| CN (1) | CN1131665A (tr) |
| AU (1) | AU4055895A (tr) |
| BR (1) | BR9505981A (tr) |
| CA (1) | CA2165922A1 (tr) |
| IL (1) | IL116518A0 (tr) |
| PL (1) | PL311999A1 (tr) |
| TR (1) | TR199501631A2 (tr) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW397831B (en) * | 1994-07-15 | 2000-07-11 | Meiji Seika Kaisha | The anti-platelet-agglutination hexahydrogenated pyridine and its derivatives |
| US6069143A (en) * | 1994-12-20 | 2000-05-30 | Smithkline Beecham Corporation | Fibrinogen receptor antagonists |
| DE19504329A1 (de) * | 1995-02-10 | 1996-08-14 | Boehringer Mannheim Gmbh | Neue Pyridyl- bzw. Pyridazinyl-Piperazinderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| WO1997031910A1 (en) * | 1996-02-28 | 1997-09-04 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| US5932582A (en) * | 1996-06-28 | 1999-08-03 | Merck & Co., Inc. | Fibrinogen receptor antagonist prodrugs |
| US5854245A (en) * | 1996-06-28 | 1998-12-29 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| US5990107A (en) * | 1996-06-28 | 1999-11-23 | Merck & Co., Inc. | Fibrinogen receptor antagonist prodrugs |
| AU721130B2 (en) * | 1996-06-28 | 2000-06-22 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| US6197961B1 (en) | 1996-10-07 | 2001-03-06 | Koei Chemical Co., Ltd. | Process for preparing acid salts of γ-(piperidyl)butyric acid |
| US5945545A (en) * | 1996-12-13 | 1999-08-31 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| AU7409300A (en) * | 1999-08-20 | 2001-03-19 | Boehringer Ingelheim Pharma Kg | Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| CZ20011872A3 (cs) * | 1999-09-29 | 2002-03-13 | Ortho-Mcneil Pharmaceutical, Inc. | Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny |
| EP1533310A1 (en) * | 1999-09-29 | 2005-05-25 | Ortho-McNeil Pharmaceutical, Inc. | Isonipecotamides for the treatment of integrin-mediated disorders |
| USRE39921E1 (en) | 1999-10-07 | 2007-11-13 | Smithkline Beecham Corporation | Chemical compounds |
| GB9923748D0 (en) | 1999-10-07 | 1999-12-08 | Glaxo Group Ltd | Chemical compounds |
| GB0025354D0 (en) | 2000-10-17 | 2000-11-29 | Glaxo Group Ltd | Chemical compounds |
| GB0108594D0 (en) * | 2001-04-05 | 2001-05-23 | Glaxo Group Ltd | Chemical compounds |
| JP2004529918A (ja) * | 2001-04-09 | 2004-09-30 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | インテグリンに由来する疾患の治療のためのキナゾリンおよびキナゾリン類似化合物 |
| FR2829766A1 (fr) * | 2001-09-14 | 2003-03-21 | Lipha | Derives d'oxamates comportant un heterocycle azote diversement substitue |
| GB0203022D0 (en) | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
| EP1472222A1 (en) | 2002-02-08 | 2004-11-03 | Glaxo Group Limited | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases |
| GB0203020D0 (en) | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
| WO2003076374A1 (fr) * | 2002-03-12 | 2003-09-18 | Shionogi & Co., Ltd. | Procede de production de derive d'acide trans-4-amino-1-cyclohexanecarboxylique |
| ES2355139T3 (es) * | 2002-08-16 | 2011-03-23 | Janssen Pharmaceutica Nv | Compuestos de piperidinilo que unen selectivamente a receptores de integrinas. |
| US7291615B2 (en) * | 2003-05-01 | 2007-11-06 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| WO2007016496A2 (en) * | 2005-08-02 | 2007-02-08 | Neurogen Corporation | Dipiperazinyl ketones and related analogues |
| PL2041088T3 (pl) | 2006-06-28 | 2014-07-31 | Amgen Inc | Inhibitory transportera-1 glicyny |
| WO2011015953A2 (en) * | 2009-08-04 | 2011-02-10 | Haren Treasurer | Greater utility with thyroid hormone |
| CN105175360B (zh) * | 2015-09-06 | 2017-12-15 | 洛阳师范学院 | 醚类芳基哌嗪衍生物及其盐、制备方法和用途 |
| US11033539B2 (en) | 2015-11-06 | 2021-06-15 | Neurocrine Biosciences, Inc. | Compounds of formulas (VII), (VIII), (IX), (XI), (XII), (XIII), and (XIV) as muscarinic receptor 4(M4) antagonists for treating neurological diseases |
| EA039638B1 (ru) * | 2016-01-06 | 2022-02-21 | Нейрокрин Байосайенсиз, Инк. | Антагонисты мускаринового рецептора 4 и способы их применения |
| US20220388998A1 (en) * | 2019-06-28 | 2022-12-08 | Chdi Foundation, Inc | Rho kinase inhibitors and compositions and methods of use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2708187A1 (de) * | 1977-02-25 | 1978-08-31 | Thomae Gmbh Dr K | Neue pyrido-pyridazin-one |
| ZA825719B (en) * | 1981-09-03 | 1983-06-29 | Recordati Chem Pharm | Alkanoylanilides |
| PH19166A (en) * | 1982-09-04 | 1986-01-16 | Pfizer | Dihydropyridined,pharmaceutical compositions and method of use |
| DE3302021A1 (de) * | 1983-01-22 | 1984-07-26 | Basf Ag, 6700 Ludwigshafen | 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung |
| US4755512A (en) * | 1984-04-11 | 1988-07-05 | Bristol-Myers Company | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities |
| US4895846A (en) * | 1984-04-11 | 1990-01-23 | Bristol-Myers Company | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moieties |
| GB8603120D0 (en) * | 1986-02-07 | 1986-03-12 | Pfizer Ltd | Anti-dysrhythmia agents |
| JP2556722B2 (ja) * | 1988-02-18 | 1996-11-20 | 興和株式会社 | 新規なスルホンアミド化合物 |
| EP0350145A3 (en) * | 1988-04-28 | 1990-07-04 | Yamanouchi Pharmaceutical Co. Ltd. | Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both |
| US5196428A (en) * | 1992-04-03 | 1993-03-23 | Bristol-Myers Squibb Company | Imidazo[4,5-b]qinolinyl oxy alkyl ureas |
| AU692439B2 (en) * | 1993-03-29 | 1998-06-11 | Zeneca Limited | Heterocyclic compounds as platelet aggregation inhibitors |
| ATE202345T1 (de) * | 1993-03-29 | 2001-07-15 | Astrazeneca Ab | Heterozyklische derivate als plätchenaggregationsinhibitoren |
-
1995
- 1995-12-13 US US08/572,256 patent/US5700801A/en not_active Expired - Fee Related
- 1995-12-19 AU AU40558/95A patent/AU4055895A/en not_active Abandoned
- 1995-12-19 EP EP95120118A patent/EP0718287A3/de not_active Withdrawn
- 1995-12-21 PL PL95311999A patent/PL311999A1/xx unknown
- 1995-12-21 TR TR95/01631A patent/TR199501631A2/tr unknown
- 1995-12-21 BR BR9505981A patent/BR9505981A/pt not_active Application Discontinuation
- 1995-12-21 CA CA002165922A patent/CA2165922A1/en not_active Abandoned
- 1995-12-22 IL IL11651895A patent/IL116518A0/xx unknown
- 1995-12-23 CN CN95121745A patent/CN1131665A/zh active Pending
- 1995-12-25 JP JP7336774A patent/JPH08231509A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1131665A (zh) | 1996-09-25 |
| US5700801A (en) | 1997-12-23 |
| IL116518A0 (en) | 1996-03-31 |
| EP0718287A2 (de) | 1996-06-26 |
| EP0718287A3 (de) | 1997-01-29 |
| JPH08231509A (ja) | 1996-09-10 |
| CA2165922A1 (en) | 1996-06-24 |
| PL311999A1 (en) | 1996-06-24 |
| BR9505981A (pt) | 1997-12-23 |
| AU4055895A (en) | 1996-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199501631A2 (tr) | Piperazin türevleri,bu bilesimleri iceren ilaclar,bunlarin kullanimi ve imal edilmesi usulü. | |
| TR199501634A2 (tr) | Piperazin türevleri,bunlari ihtiva eden ilaclar,bunlarin kullanilmasi ve imal edilmesine mahsus usul. | |
| TR199600438A2 (tr) | Piperazin türevleri. | |
| ATE70833T1 (de) | Piperazinyl-heterocyclische derivate. | |
| DZ2964A1 (fr) | Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant. | |
| TR199501673A1 (tr) | Aerosol ilac formülleri. | |
| NO307459B1 (no) | Piperazinderivater, samt farmasøytiske preparater inneholdende slike | |
| DK0831829T3 (da) | Heterocykliske, ringkondenserede pyrimidinderivater | |
| ATE187063T1 (de) | Arzneimittel | |
| DE69115229D1 (de) | Arzneimittel. | |
| NL300161I2 (nl) | Carbostyrilderivaten. | |
| FI864272A (fi) | Infusionsloesningar av 1-cyklopropyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-kinolin-3 -karboxylsyra. | |
| DE69204283D1 (de) | Gelstift antiperspiranten enthaltend 2-oxazolidinon-derivate und herstellungsverfahren. | |
| NO932176D0 (no) | Kinolin-, naftyridin- og pyridobenzoksazinderivater | |
| DE59813899D1 (de) | Piperazin-derivate | |
| FR2735127B1 (fr) | Nouvelles piperazines heteroaromatiques utiles comme medicaments. | |
| DE3684948D1 (de) | Imidderivate, ihre herstellung und anwendung. | |
| NL194239B (nl) | Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten. | |
| DE3869167D1 (de) | Phenyltriazol-derivate und insectizid. | |
| MX9206408A (es) | Conjugados policiclicos. | |
| NO972937D0 (no) | Farmasöytiske piperazinforbindelser | |
| NL970029I2 (nl) | Benzimidazoolderivaten, bereiding en therapeutische toepassing. | |
| NO912344D0 (no) | Benzopuranderivater og heterocykliske derivater derav. | |
| NL191307C (nl) | Analgetisch werkzame piperazinederivaten en farmaceutische preparaten, die deze derivaten bevatten. | |
| TR199801871A3 (tr) | Bifenilsulfonilsiyanamidler üretim yöntemi ve ilaç olarak kullanimlari. |